ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF15.180

F15.180

Billable

Other stimulant abuse with stimulant-induced anxiety disorder

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F15.180 is a billable code used to indicate a diagnosis of other stimulant abuse with stimulant-induced anxiety disorder.

Key Diagnostic Point:

F15.180 refers to a condition characterized by the abuse of stimulants that are not classified under other specific categories, leading to the development of anxiety disorders as a direct consequence of stimulant use. Stimulants, such as amphetamines and cocaine, can induce heightened levels of anxiety, agitation, and panic attacks, particularly when used in excessive amounts or over prolonged periods. The diagnosis requires a thorough assessment of the patient's substance use history, including the type of stimulant abused, frequency, and duration of use. Clinicians must also evaluate the severity of anxiety symptoms, which may include restlessness, rapid heartbeat, and excessive worry. Treatment typically involves a combination of behavioral therapies and, in some cases, pharmacological interventions to manage anxiety symptoms. It is crucial for healthcare providers to monitor patients closely for withdrawal symptoms and potential relapse, as stimulant use disorder can lead to significant impairment in social, occupational, and personal functioning.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of stimulants that can be abused, complicating diagnosis.
  • Need for comprehensive documentation of both substance use and anxiety symptoms.
  • Differentiation from other anxiety disorders not related to substance use.
  • Potential for co-occurring mental health disorders.

Audit Risk Factors

  • Inadequate documentation of substance use history.
  • Failure to document the specific anxiety symptoms experienced.
  • Misclassification of stimulant-induced anxiety as a primary anxiety disorder.
  • Lack of evidence for treatment plans and follow-up care.

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed history of substance use, mental status examination, and treatment plan.

Common Clinical Scenarios

Patients presenting with anxiety symptoms following stimulant use, requiring assessment for substance use disorder.

Billing Considerations

Consideration of co-occurring disorders and the need for integrated treatment approaches.

Addiction Medicine

Documentation Requirements

Comprehensive assessment of substance use patterns, withdrawal symptoms, and treatment response.

Common Clinical Scenarios

Patients in withdrawal from stimulants presenting with anxiety and agitation.

Billing Considerations

Focus on harm reduction strategies and relapse prevention.

Coding Guidelines

Inclusion Criteria

Use F15.180 When
  • According to ICD
  • 10 guidelines, F15
  • 180 should be used when there is clear evidence of stimulant abuse leading to anxiety symptoms
  • Documentation must support the diagnosis, including the timeline of substance use and onset of anxiety symptoms

Exclusion Criteria

Do NOT use F15.180 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99214CPT Code

Established patient office visit, level 4

Clinical Scenario

Used for follow-up visits for patients with stimulant-induced anxiety disorder.

Documentation Requirements

Document history of present illness, review of systems, and treatment plan.

Specialty Considerations

Psychiatry may require additional mental status examination details.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of stimulant-related disorders, improving the accuracy of diagnoses and treatment planning. F15.180 provides a clear framework for identifying patients with both stimulant abuse and anxiety disorders.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of stimulant-related disorders, improving the accuracy of diagnoses and treatment planning. F15.180 provides a clear framework for identifying patients with both stimulant abuse and anxiety disorders.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of stimulant-related disorders, improving the accuracy of diagnoses and treatment planning. F15.180 provides a clear framework for identifying patients with both stimulant abuse and anxiety disorders.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between F15.180 and F15.10?

F15.180 includes the presence of anxiety symptoms induced by stimulant use, while F15.10 refers to stimulant use disorder without specific anxiety symptoms.